216 related articles for article (PubMed ID: 29369007)
1. Combination therapy Eve and Pac to induce apoptosis in cervical cancer cells by targeting PI3K/AKT/mTOR pathways.
Dong P; Hao F; Dai S; Tian L
J Recept Signal Transduct Res; 2018 Feb; 38(1):83-88. PubMed ID: 29369007
[TBL] [Abstract][Full Text] [Related]
2. Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells.
Tsai JP; Lee CH; Ying TH; Lin CL; Lin CL; Hsueh JT; Hsieh YH
Oncotarget; 2015 Oct; 6(30):28851-66. PubMed ID: 26311737
[TBL] [Abstract][Full Text] [Related]
3. Anti-proliferative effect of RCE-4 from Reineckia carnea on human cervical cancer HeLa cells by inhibiting the PI3K/Akt/mTOR signaling pathway and NF-κB activation.
Bai C; Yang X; Zou K; He H; Wang J; Qin H; Yu X; Liu C; Zheng J; Cheng F; Chen J
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):573-84. PubMed ID: 26935715
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of everolimus in combination with paclitaxel on adriamycin-resistant breast cancer cell line MDA-MB-231.
Xu T; Liu P; Li Q; Shi C; Wang X
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):828-834. PubMed ID: 33218396
[TBL] [Abstract][Full Text] [Related]
5. Everolimus reduces postoperative arthrofibrosis in rabbits by inducing autophagy-mediated fibroblast apoptosis by PI3K/Akt/mTOR signaling pathway.
Liu Y; Zhang Z; Yan L; Li X; Zhang J; Zhang X; Zhu D; Sun Y; Jiang Q
Biochem Biophys Res Commun; 2020 Nov; 533(1):1-8. PubMed ID: 32919704
[TBL] [Abstract][Full Text] [Related]
6. Cyanidin-3-O-glucoside and cisplatin inhibit proliferation and downregulate the PI3K/AKT/mTOR pathway in cervical cancer cells.
Li X; Zhao J; Yan T; Mu J; Lin Y; Chen J; Deng H; Meng X
J Food Sci; 2021 Jun; 86(6):2700-2712. PubMed ID: 33908630
[TBL] [Abstract][Full Text] [Related]
7. SRSF3 Restriction Eases Cervical Cancer Cell Viability and Metastasis via Adjusting PI3K/AKT/mTOR Signaling Pathway.
Zhang L; Li J; Zhang L
Contrast Media Mol Imaging; 2022; 2022():8497078. PubMed ID: 36237584
[TBL] [Abstract][Full Text] [Related]
8. Combination effects of paclitaxel with signaling inhibitors in endometrial cancer cells.
Xu C; Li X; Li T; Wang X; Yang Y; Xiao L; Shen H
Asian Pac J Cancer Prev; 2011; 12(11):2951-7. PubMed ID: 22393970
[TBL] [Abstract][Full Text] [Related]
9. Butein suppresses cervical cancer growth through the PI3K/AKT/mTOR pathway.
Bai X; Ma Y; Zhang G
Oncol Rep; 2015 Jun; 33(6):3085-92. PubMed ID: 25962638
[TBL] [Abstract][Full Text] [Related]
10. A study on the mechanism of rapamycin mediating the sensitivity of pancreatic cancer cells to cisplatin through PI3K/AKT/mTOR signaling pathway.
Li B; Yang J; Lu Z; Liu B; Liu F
J BUON; 2019; 24(2):739-745. PubMed ID: 31128031
[TBL] [Abstract][Full Text] [Related]
11. Anti-proliferative and pro-apoptotic effects of 3,3'-diindolylmethane in human cervical cancer cells.
Zhu J; Li Y; Guan C; Chen Z
Oncol Rep; 2012 Sep; 28(3):1063-8. PubMed ID: 22736073
[TBL] [Abstract][Full Text] [Related]
12. Effect of combined treatment with a pan-PI3K inhibitor or an isoform-specific PI3K inhibitor and everolimus on cell proliferation in GH-secreting pituitary tumour in an experimental setting.
Pivonello C; Patalano R; Solari D; Auriemma RS; Frio F; Vitulli F; Grasso LFS; Di Cera M; De Martino MC; Cavallo LM; Cappabianca P; Colao A; Pivonello R
Endocrine; 2018 Dec; 62(3):663-680. PubMed ID: 30066286
[TBL] [Abstract][Full Text] [Related]
13. miR-338 modulates proliferation and autophagy by PI3K/AKT/mTOR signaling pathway in cervical cancer.
Lu R; Yang Z; Xu G; Yu S
Biomed Pharmacother; 2018 Sep; 105():633-644. PubMed ID: 29898430
[TBL] [Abstract][Full Text] [Related]
14. 6-Shogaol from ginger shows anti-tumor effect in cervical carcinoma via PI3K/Akt/mTOR pathway.
Pei XD; He ZL; Yao HL; Xiao JS; Li L; Gu JZ; Shi PZ; Wang JH; Jiang LH
Eur J Nutr; 2021 Aug; 60(5):2781-2793. PubMed ID: 33416981
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human cervical cancer cell growth by Salviolone is mediated via autophagy induction, cell migration and cell invasion suppression, G2/M cell cycle arrest and downregulation of Nf-kB/m-TOR/PI3K/AKT pathway.
Zhang Y; Li G; Ji C
J BUON; 2018; 23(6):1739-1744. PubMed ID: 30610802
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel.
Faried LS; Faried A; Kanuma T; Nakazato T; Tamura T; Kuwano H; Minegishi T
Eur J Cancer; 2006 May; 42(7):934-47. PubMed ID: 16540312
[TBL] [Abstract][Full Text] [Related]
17. Fabrication of bimetallic Ag@ZnO nanocomposite and its anti-cancer activity on cervical cancer via impeding PI3K/AKT/mTOR pathway.
Yin Q; Zhou Q; Hu J; Weng J; Liu S; Yin L; Long L; Tong Y; Tang K; Bai S; Ou L
J Trace Elem Med Biol; 2024 Jul; 84():127437. PubMed ID: 38564977
[TBL] [Abstract][Full Text] [Related]
18. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer.
Chen X; Zhao M; Hao M; Sun X; Wang J; Mao Y; Zu L; Liu J; Shen Y; Wang J; Shen K
Mol Cancer Res; 2013 Oct; 11(10):1269-78. PubMed ID: 23814023
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative activity of Farnesol in HeLa cervical cancer cells is mediated via apoptosis induction, loss of mitochondrial membrane potential (ΛΨm) and PI3K/Akt signalling pathway.
Wang YL; Liu HF; Shi XJ; Wang Y
J BUON; 2018; 23(3):752-757. PubMed ID: 30003747
[TBL] [Abstract][Full Text] [Related]
20. Elevated phosphatidylinositol 3-kinase activation and its clinicopathological significance in cervical cancer.
Zhang XY; Zhang HY; Zhang PN; Lu X; Sun H
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):237-44. PubMed ID: 18395956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]